NPAF Urges Government Officials to Preserve Access to ESAs for Cancer Patients

NPAF and its Scientific Advisory Board, representing millions of cancer and other chronically ill patients, have joined the chorus of leading physicians and researchers in the field of hematology and oncology in urging the Centers for Medicare and Medicaid Services (CMS) to maintain full patient access to Erythropoiesis Stimulating Agents (ESAs).

Tennessee Patient Advocate Day June 19th, 2007

NPAF is pleased to announce a Patient Advocate Day on June 19th, 2007 in Tennessee. This is part of a national initiative by the National Patient Advocate Foundation to draw awareness to patient advocacy.

View the Tennessee Proclamation...